evidence: UFT/LV significantly prolonged the RFS compared with surgery alone with the hazard ratio of 0.56 (95% confidence interval, 0.38–0.83; P = 0.003)
intervention: Uracil-tegafur and leucovorin
comparator: Control
outcome: Recurrence-free survival